Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dyclonine for Visibility During Colonoscopy Bowel Cleansing
NCT03352700Phase 4Unknown
- Sponsor
- Changhai Hospital
- Start
- Dec 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dyclonine in colorectal cancer (CRC), sponsored by Changhai Hospital. Primary endpoint: Amount of air bubbles at 2 days. Status: unknown.
02
Drugs
dyclonine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03352700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03352700.